secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269454
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q3 sales $61.0M (+11%), EPS $0.75 (+54%); raises FY guidance
---------------------------------------------------------------------

- Q3 sales $61.0M (+11% YoY, +12% organic); Grafts +23%, Shunts +18%, Artegraft +33%.
- GAAP diluted EPS $0.75 (+54%); adjusted EPS $0.62 (+27%).
- Adjusted gross margin 70.8% (up 300 bps) on pricing and manufacturing efficiencies.
- Full-year 2025 guidance raised: sales $247-249M, EPS $2.48-2.53 (midpoint +30%).
- Quarterly dividend $0.20/share, payable Dec 4 to holders of record Nov 20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000119312525269454/0001193125-25-269454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000119312525269454/d35939d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer